Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Penile Neoplasms × Ifosfamide × Clear all

Phase

Phase 2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma 7 Sarcoma, Synovial 6 Rhabdomyosarcoma 6 Neurofibrosarcoma 6 Liposarcoma 6 Leukemia 6 Leiomyosarcoma 6 Histiocytoma, Malignant Fibrous 6 Hemangiosarcoma 6 Fibrosarcoma 6 Malignant mesenchymal tumor 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Testicular Neoplasms 4 Teratoma 4 Ovarian Neoplasms 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Hemangiopericytoma, Malignant 4 Testicular Germ Cell Tumor 3 Seminoma 3 Neuroblastoma 3 Neoplasm Metastasis 3 Hodgkin Disease 3 Endodermal Sinus Tumor 3 Burkitt Lymphoma 3 Uterine Cervical Neoplasms 2 Sarcoma, Ewing 2

Interventions

Vaccines, Synthetic 1 Paclitaxel 1 Ifosfamide 1 Fentanyl 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02305654 2025-04-02

InPACT

Institute of Cancer Research, United Kingdom

Phase 3 Recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡